27 February 2021 : Database Analysis
Sites and Causes of Infection in Patients with Sepsis-Associated Liver Dysfunction: A Population Study from the Medical Information Mart for Intensive Care III
Jinfeng Lin1BCEF, Chunfeng Gu2CD, Suyan Zhang1B, Lijun Tian1B, Ke Ren1B, Zhilong Cao1B, Xudong Han1AG*DOI: 10.12659/MSM.928928
Med Sci Monit 2021; 27:e928928
Table 5 Subgroup analysis of distribution of pathogens in the 2 groups.
| Pathogens | Control (n, %) | SALD (n, %) | P value |
|---|---|---|---|
| 35006 | 7406 | ||
| Coagulase-positive | 4910 (14.03) | 740 (9.99) | <0.001 |
| Coagulase-negative | 3514 (10.04) | 732 (9.88) | 0.688 |
| 2255 (6.44) | 575 (7.76) | <0.001 | |
| Methicillin-resistant | 805 (2.30) | 84 (1.13%) | <0.001 |
| 741 (2.12) | 97 (1.31) | <0.001 | |
| 698 (1.99) | 115 (1.55) | 0.012 | |
| β (group B) | 222 (0.63) | 24 (0.32) | 0.120 |
| Viridans | 215 (0.61) | 56 (0.76) | 0.164 |
| 212 (0.61) | 35 (0.47) | 0.182 | |
| 185 (0.53) | 118 (1.59) | <0.001 | |
| 165 (0.47) | 37 (0.50) | 0.718 | |
| β | 177 (0.51) | 19 (0.26) | 0.004 |
| 138 (0.39) | 50 (0.68) | 0.001 | |
| α | 99 (0.28) | 25 (0.34) | 0.413 |
| Other gram-positive bacteria | 739 (2.11) | 112 (1.51) | 0.001 |
| 2210 (6.31) | 387 (5.23) | <0.001 | |
| 1595 (4.56) | 375 (5.06) | 0.060 | |
| 1204 (3.44) | 274 (3.70) | 0.267 | |
| 498 (1.42) | 33 (0.45) | <0.001 | |
| 408 (1.17) | 142 (1.92) | <0.001 | |
| 306 (0.87) | 79 (1.07) | 0.112 | |
| 278 (0.79) | 18 (0.24) | <0.001 | |
| 255 (0.73) | 98 (1.32) | <0.001 | |
| 222 (0.63) | 85 (1.15) | <0.001 | |
| 209 (0.60) | 77 (1.04) | <0.001 | |
| 177 (0.51) | 44 (0.59) | 0.337 | |
| 163 (0.47) | 54 (0.73) | 0.004 | |
| Proteus species | 104 (0.30) | 11 (0.15) | 0.031 |
| Other Gram-negative bacteria | 2605 (7.44) | 513 (6.93) | 0.123 |
| Yeast | 5183 (14.81) | 1198 (16.18) | 0.003 |
| 66 (0.19) | 10 (0.14) | 0.367 | |
| 665 (1.90) | 266 (3.59) | <0.001 | |
| 148 (0.42) | 73 (0.99) | <0.001 | |
| 97 (0.28) | 39 (0.53) | 0.001 | |
| Herpes simplex virus type 1 | 94 (0.27) | 35 (0.47) | 0.006 |
| Herpes simplex virus type 2 | 24 (0.07) | 4 (0.05) | 0.807 |
| Other virus | 61 (0.17) | 14 (0.19) | 0.761 |
| 3359 (9.60) | 758 (10.23) | 0.091 | |
| SALD – sepsis-associated liver dysfunction. | |||






